Tetraneuron
Biotechnology company that develops a gene therapy with a multifactorial approach against Alzheimer's disease and other neurodegenerative diseases
Valencia, Spaintetraneuron.com/es ↗
Total raised
€9.9M
€9,900,000
Funding rounds
2
Investors
1
distinct backers
Active since
2022-12
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood19
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-21 | Other | €4.9M | GIMIC Ventures | View deal → |
| 2022-12-27 | Other | €5.0M | — | View deal → |
Investors
1Related news
- Tetraneuron alcanza los €5 millones en una ronda para su terapia génica contra el alzhéimerwebcapitalriesgo.com · 2022-12
- elreferente.es
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel